These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 2144325

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Congenital leukaemia and the neonatal myeloproliferative disorders associated with Down's syndrome.
    Weinstein HJ.
    Clin Haematol; 1978 Feb; 7(1):147-54. PubMed ID: 148990
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Acute myeloid leukemia in children with Down syndrome].
    Creutzig U, Ritter J, Ludwig WD, Niemeyer C, Reinisch I, Stollmann-Gibbels B, Zimmermann M, Harbott J.
    Klin Padiatr; 1995 Feb; 207(4):136-44. PubMed ID: 7564143
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
    Langebrake C, Creutzig U, Reinhardt D.
    Klin Padiatr; 2005 Feb; 217(3):126-34. PubMed ID: 15858703
    [Abstract] [Full Text] [Related]

  • 9. Transient myeloproliferative syndrome/transient acute myeloid leukemia in a newborn with Down syndrome: a case report and literature review.
    D'Angelo G, Merlo P.
    Lab Hematol; 2003 Feb; 9(1):38-41. PubMed ID: 12661826
    [Abstract] [Full Text] [Related]

  • 10. Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome. An immunophenotypic analysis.
    Karandikar NJ, Aquino DB, McKenna RW, Kroft SH.
    Am J Clin Pathol; 2001 Aug; 116(2):204-10. PubMed ID: 11488066
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Down's syndrome and leukemia].
    Bermúdez Cortés M, Verdeguer Miralles A, Jovaní Casano C, Cañete Nieto A, Fernández JM, Ferris Tortajada J, Castel Sánchez V.
    An Esp Pediatr; 1998 Jun; 48(6):593-8. PubMed ID: 9662842
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Transient myeloproliferative disorder and acute myeloid leukemia: study of six neonatal cases with long-term follow-up.
    Liang DC, Ma SW, Lu TH, Lin ST.
    Leukemia; 1993 Oct; 7(10):1521-4. PubMed ID: 8412314
    [Abstract] [Full Text] [Related]

  • 15. Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndrome.
    Boztug H, Schumich A, Pötschger U, Mühlegger N, Kolenova A, Reinhardt K, Dworzak M.
    Cytometry B Clin Cytom; 2013 Oct; 84(6):370-8. PubMed ID: 23450818
    [Abstract] [Full Text] [Related]

  • 16. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A.
    Pathobiology; 2007 Oct; 74(2):97-114. PubMed ID: 17587881
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Unrelated donor bone marrow transplantation for acute leukemia in patients with Down's syndrome.
    Pawlowska AB, Davies SM, Orchard PJ, Wagner JE, Ramsay NK.
    Bone Marrow Transplant; 1996 Aug; 18(2):453-5. PubMed ID: 8864463
    [Abstract] [Full Text] [Related]

  • 19. Bone marrow transplantation for the treatment of haematological disorders in Down's syndrome: toxicity and outcome.
    Rubin CM, Mick R, Johnson FL.
    Bone Marrow Transplant; 1996 Sep; 18(3):533-40. PubMed ID: 8879614
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.